Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 2
1989 1
1993 1
1995 1
1996 2
1998 2
2000 1
2001 4
2002 5
2003 1
2004 1
2005 1
2006 2
2007 3
2008 3
2009 3
2010 1
2013 3
2014 4
2015 3
2016 2
2017 3
2018 5
2019 7
2020 6
2021 5
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management.
Szuber N, Elliott M, Tefferi A. Szuber N, et al. Am J Hematol. 2020 Feb;95(2):212-224. doi: 10.1002/ajh.25688. Epub 2019 Dec 30. Am J Hematol. 2020. PMID: 31769070 Free article. Review.
DISEASE UPDATES: Increasingly comprehensive genetic profiling of CNL has disclosed a complex genomic landscape and additional prognostically relevant mutational combinations. Though prognostic determination and therapeutic decision-making remain challenging, emergin …
DISEASE UPDATES: Increasingly comprehensive genetic profiling of CNL has disclosed a complex genomic landscape and additional prognostica …
Chronic neutrophilic leukemia: 2022 update on diagnosis, genomic landscape, prognosis, and management.
Szuber N, Elliott M, Tefferi A. Szuber N, et al. Am J Hematol. 2022 Apr;97(4):491-505. doi: 10.1002/ajh.26481. Epub 2022 Feb 9. Am J Hematol. 2022. PMID: 35089603 Free article.
DISEASE UPDATES: Increasingly comprehensive genetic profiling in CNL, including new data on clonal evolution, has disclosed a complex genomic landscape with additional mutations and combinations thereof driving disease progression and drug resistance. Although accurate prognos …
DISEASE UPDATES: Increasingly comprehensive genetic profiling in CNL, including new data on clonal evolution, has disclosed a complex genomi …
Genomic landscape of neutrophilic leukemias of ambiguous diagnosis.
Zhang H, Wilmot B, Bottomly D, Dao KT, Stevens E, Eide CA, Khanna V, Rofelty A, Savage S, Reister Schultz A, Long N, White L, Carlos A, Henson R, Lin C, Searles R, Collins RH, DeAngelo DJ, Deininger MW, Dunn T, Hein T, Luskin MR, Medeiros BC, Oh ST, Pollyea DA, Steensma DP, Stone RM, Druker BJ, McWeeney SK, Maxson JE, Gotlib JR, Tyner JW. Zhang H, et al. Blood. 2019 Sep 12;134(11):867-879. doi: 10.1182/blood.2019000611. Epub 2019 Jul 31. Blood. 2019. PMID: 31366621 Free PMC article.
Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
Dao KT, Gotlib J, Deininger MMN, Oh ST, Cortes JE, Collins RH Jr, Winton EF, Parker DR, Lee H, Reister A, Schultz, Savage S, Stevens, Brockett C, Subbiah N, Press RD, Raess PW, Cascio M, Dunlap J, Chen Y, Degnin C, Maxson JE, Tognon CE, Macey T, Druker BJ, Tyner JW. Dao KT, et al. J Clin Oncol. 2020 Apr 1;38(10):1006-1018. doi: 10.1200/JCO.19.00895. Epub 2019 Dec 27. J Clin Oncol. 2020. PMID: 31880950 Free PMC article. Clinical Trial.
Current Management of Chronic Neutrophilic Leukemia.
Szuber N, Tefferi A. Szuber N, et al. Curr Treat Options Oncol. 2021 Jun 7;22(7):59. doi: 10.1007/s11864-021-00856-x. Curr Treat Options Oncol. 2021. PMID: 34097138 Review.
For this reason, coupled with CNL's typically aggressive clinical course, allogeneic HSCT remains the primary recommended therapy for eligible patients. ...
For this reason, coupled with CNL's typically aggressive clinical course, allogeneic HSCT remains the primary recommended therapy for …
Chronic neutrophilic leukemia: novel mutations and their impact on clinical practice.
Tefferi A, Elliott M, Pardanani A. Tefferi A, et al. Curr Opin Hematol. 2015 Mar;22(2):171-6. doi: 10.1097/MOH.0000000000000114. Curr Opin Hematol. 2015. PMID: 25575036 Review.
Herein, we focus on recently described mutations in CNL and their impact on diagnosis, prognosis and treatment. RECENT FINDINGS: In 2013, membrane-proximal CSF3R mutations, most frequently CSF3RT618I, were described in CNL and aCML. ...The identification of CNL-specific mo …
Herein, we focus on recently described mutations in CNL and their impact on diagnosis, prognosis and treatment. RECENT FINDINGS: In 2 …
Chronic neutrophilic leukemia: new science and new diagnostic criteria.
Szuber N, Tefferi A. Szuber N, et al. Blood Cancer J. 2018 Feb 13;8(2):19. doi: 10.1038/s41408-018-0049-8. Blood Cancer J. 2018. PMID: 29440636 Free PMC article. Review.
Further, the natural history of the disease is reviewed as well as potential prognostic variables. Finally, we summarize and discuss current treatment options as well as prospective novel therapeutic targets in hopes that they will yield meaningful improvements in patient …
Further, the natural history of the disease is reviewed as well as potential prognostic variables. Finally, we summarize and discuss …
Update on CML-Like Disorders.
Cross NCP. Cross NCP. Clin Lymphoma Myeloma Leuk. 2020 Sep;20 Suppl 1:S101-S102. doi: 10.1016/S2152-2650(20)30477-8. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32862848
Chronic myeloid leukemia (CML) is defined for many years as BCR-ABL1 positive disease, but older publications refer to a poor prognosis, clinically heterogeneous entity termed 'BCR-ABL1 negative CML' constituting about 5% of CML cases. ...
Chronic myeloid leukemia (CML) is defined for many years as BCR-ABL1 positive disease, but older publications refer to a poor prognosis …
71 results